glp-1 substance abuse and Use Disorder: Research and Clinical Insights GLP-1 drugs may fight addiction

Nadya Morrow is the recipient of a CIHR CGS-Doctoral Award

Here, we show in both ex vivo and in vivo models of ischemic injury that treatment with GLP-1(2836), a neutral endopeptidasegenerated (NEP-generated) metabolite of GLP-1, was as cardioprotective as GLP-1 and was abolished by scrambling its amino acid sequence

Be skeptical of high absorption hype: formulations like dihydroberberine and berberine phytosome have small human pharmacokinetic studies showing higher blood levels than standard berberine, but that does not automatically mean better real-world weight loss

Insider Tip: Youll get the most accurate result by collecting your blood sample when experiencing typical allergy symptoms, rather than collecting a sample when symptoms are mild or not present

in HFpEF, the prevalence of obesity reaches up to 80%